My Cancer Genome: Genetically Informed Cancer Medicine

  • Home
  • DIRECT
  • About Us
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Anaplastic Large Cell Lymphoma
  • Basal Cell Carcinoma
  • Bladder Cancer
  • Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Colorectal Cancer
  • GIST
  • Gastric Cancer
  • Glioma
  • Inflammatory Myofibroblastic Tumor
  • Lung Cancer
  • Medulloblastoma
  • Melanoma
  • Myelodysplastic Syndromes
  • Neuroblastoma
  • Ovarian Cancer
  • Prostate Cancer
  • Rhabdomyosarcoma
  • Thymic Carcinoma
  • Thyroid Cancer
  • Molecular Medicine
    • Anticancer Agents
    • Circulating Tumor DNA
    • Detecting Gene Alterations in Cancers
    • Immunotherapy in Cancer
    • Overview of Targeted Therapies for Cancer
    • Pathways
    • Types of Molecular Tumor Testing
  • Take Our Survey
  • Glossary
  • News
  • Our Team
  • Acknowledgements

Protein Degradation/Ubiquitination

The protein degradation/ubiquitination pathway involves the regulated post-translational modification of substrate proteins via the addition of ubiquitin. Ubiquitination of substrate proteins signals the protein for degradation by the proteasome. Ubiquitination can also alter protein activity and interactions. The addition of ubiquitin is carried out by specific ubiquitin enzymes.

protein degradation color

Figure 1. Protein ubiquitination is carried out by enzyme complexes such as ubiquitin-E1, ubiquitin-E2, and ubiquitin-E3. Once the protein has been tagged with ubiquitin, it is recognized for degradation by the proteasome. The proteasome degrades the substrate protein into peptide subunits. Click here to open a larger version of this image in a new window.

Upstream Pathways

  • DNA damage/repair
  • Cell cycle control

Genes Involved in the Pathway

  • BTRC (ubiquitination-E3 ligase)
  • ITCH (ubiquitination-E3 ligase)
  • MDM2 (ubiquitination-E3 ligase)
  • NEDD4L (ubiquitination-E3 ligase)
  • PARK2 (ubiquitination-E3 ligase)
  • UBA1 (ubiquitination-E1 ligase)
  • UBE2D2 (ubiquitination-E2 ligase)
  • UBR5 (ubiquitination-E3 ligase)

Last Updated: May 24, 2016

Disclaimer: The information presented at MyCancerGenome.org is compiled from sources believed to be reliable. Extensive efforts have been made to make this information as accurate and as up-to-date as possible. However, the accuracy and completeness of this information cannot be guaranteed. Despite our best efforts, this information may contain typographical errors and omissions. The contents are to be used only as a guide, and health care providers should employ sound clinical judgment in interpreting this information for individual patient care.

  • MCG Home |
  • About Us |
  • Acknowledgments |
  • Give |
  • Site Map |
  • Legal |
  • APIs and Licensing
My Cancer Genome is managed by the Vanderbilt-Ingram Cancer Center   Copyright © 2010 - 2017 MY CANCER GENOME